Parents of a teen from Georgia have filed a wrongful death suit against the distributers and manufacturers of a synthetic marijuana alleged to have killed their son. Chase Burnett, 16 years old, drowned in a hot tub on March 4, 2012. This suit is believed to be the first against a manufacturer or distributer of synthetic marijuana.
According to a recent article in NaturalNews, pharmaceutical giant Eli Lilly has admitted to hundreds of millions of dollars in payoffs to doctors. Eli Lilly, founded in Indiana, makes billions of dollars every year off the sale of their patented drugs, which according to their television ads will cure whatever ails you. The company, which was originally founded by a chemist in the late 19th century now has offices in 18 countries, and its products are sold in 125 countries, with revenues exceeding $20 billion annually. Most of the drugs Eli Lilly sells are available in other countries for much less than it is here in the United States. The pharmaceutical industry claims the reason is that the health care systems of other countries demand affordable medication, and they need somebody somewhere (the U.S.) to foot the research bill, so they can get the next patents lined up before others expire. Not only are we footing the bill, we have to deal with how the pharmaceutical machine warps the medical system. Recently it has become standard operating procedure for pharmaceutical giants to pay doctors and other healthcare professionals to promote their drugs. These payments influence doctors into becoming mouthpieces for a share of the drug company's bottom line and dictating which medicines you take.
Limitations placed on the use of the active ingredient of Avandia (rosiglitazone) by the FDA last fall lead to a number of product liability and wrongful death lawsuits being filed against the drug's manufacturer, GlaxoSmithKline (GSK). The latest in these wrongful death lawsuits was recently filed in Texas.